Accelerating CAR T Cell Therapy with Flow Cytometry
Immuno-oncology has transformed the way many cancers are treated through customized cell therapies. One specific therapy uses T cells that carry chimeric antigen receptors (CAR T cells) that can treat hematologic malignancies and solid tumors.
Flow cytometry has been a crucial part of the preclinical development and clinical monitoring of these cells since these studies first began.
To learn more about how flow cytometry has been used in developing and implementing this experimental therapy, download our new white paper by filling out the form on this page.